Skip to main content
. 2022 Mar 16;49(5):467–479. doi: 10.1111/jcpe.13600

TABLE 1.

Summary of quantitative estimates of meta‐analysis when comparing outcome of acute vascular events after treatment

Outcome Studies WMD (95% CI) p‐Value I 2 (%) p‐Value
OR 2–8 weeks
2 Weeks, MI 2 0.99 (0.88–1.09) .845 67 .081
4 Weeks, MI 2 0.99 (0.90–1.07) .806 0 .828
8 Weeks, MI and IS 2 0.97 (0.94–1.01) .142 0 .627
IR 1–4 weeks
IS 2 1.04 (0.98–1.10) .191 15 .277
MI 2 0.97 (0.87–1.07) .557 58 .121
MI and IS (all) 2 1.02 (0.92–1.13) .722 61 .031
IR 5–8 weeks
IS 2 1.05 (1.011.09) .014 0 .682
MI 2 1.05 (0.95–1.07) .744 0 .345
MI and IS (all) 2 1.04 (0.97–1.10) .191 55 .132

Note: The fixed‐effect, inverse variance weighed pooled analysis was used, data given as WMD, p‐value, I 2 (heterogeneity), and CI. OR 1–7 days MI and IS and OR 2–8 weeks. IS could not be calculated due to different time periods. τ 2 could not be calculated because there were only two studies and fixed‐effect analysis was used.

Abbreviations: CI, confidence interval; IS, ischaemic stroke; MI, myocardial infarction; OR, odds ratio; WMD, weighed mean difference.

Bold value is statistically significant, pointing to increase in risk.